Literature DB >> 9737656

IL-4: role in disease and regulation of production.

P Choi, H Reiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737656      PMCID: PMC1905061          DOI: 10.1046/j.1365-2249.1998.00690.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  35 in total

Review 1.  Interleukin 4: signalling mechanisms and control of T cell differentiation.

Authors:  W E Paul
Journal:  Ciba Found Symp       Date:  1997

2.  Aberrant interleukin (IL)-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects.

Authors:  P Parronchi; M De Carli; R Manetti; C Simonelli; M P Piccinni; D Macchia; E Maggi; G Del Prete; M Ricci; S Romagnani
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

3.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

4.  Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection.

Authors:  L M Leal; D W Moss; R Kuhn; W Müller; F Y Liew
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

5.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

6.  The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells.

Authors:  Y Kamogawa; L A Minasi; S R Carding; K Bottomly; R A Flavell
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

8.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

Authors:  T Yoshimoto; W E Paul
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

9.  Cytokine-mediated regulation of chronic intestinal helminth infection.

Authors:  K J Else; F D Finkelman; C R Maliszewski; R K Grencis
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

10.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

Authors:  S J Khoury; W W Hancock; H L Weiner
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  48 in total

1.  Changes in cytokine levels during reactivation of Toxoplasma gondii infection in lungs.

Authors:  G A Filice; C R Clabots; P E Riciputi; O Goñi-Laguardia; C Pomeroy
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Naive human T cells can be a source of IL-4 during primary immune responses.

Authors:  D M Bullens; K Rafiq; A Kasran; S W Van Gool; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani.

Authors:  Sanjay Varikuti; Greta Volpedo; Noushin Saljoughian; Omar M Hamza; Gregory Halsey; Nathan M Ryan; Bren E Sedmak; Gabriella R Seidler; Tracey L Papenfuss; Steve Oghumu; Abhay R Satoskar
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

Review 4.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  IL-4 Induces Cholinergic Differentiation of Retinal Cells In Vitro.

Authors:  Marcelo Gomes Granja; Luis Eduardo Gomes Braga; Raul Carpi-Santos; Leandro de Araujo-Martins; Nilson Nunes-Tavares; Karin C Calaza; Aline Araujo Dos Santos; Elizabeth Giestal-de-Araujo
Journal:  Cell Mol Neurobiol       Date:  2015-02-15       Impact factor: 5.046

6.  Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis.

Authors:  Chiara Zingaretti; Milena Arigò; Angela Cardaci; Monica Moro; Mariacristina Crosti; Antonella Sinisi; Elisa Sugliano; Cristina Cheroni; Francesco Marabita; Renzo Nogarotto; Raoul Jean Pierre Bonnal; Paolo Marcatili; Maurizio Marconi; Annalinda Zignego; Paolo Muratori; Pietro Invernizzi; Piero Colombatto; Maurizia Brunetto; Ferruccio Bonino; Raffaele De Francesco; Jens Geginat; Massimiliano Pagani; Luigi Muratori; Sergio Abrignani; Mauro Bombaci
Journal:  Mol Cell Proteomics       Date:  2012-09-20       Impact factor: 5.911

7.  Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.

Authors:  Karolina Podsiadło; Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Lidia Strużyńska
Journal:  Inflammopharmacology       Date:  2017-02-03       Impact factor: 4.473

8.  Treatment in vitro of retinal cells with IL-4 increases the survival of retinal ganglion cells: the involvement of BDNF.

Authors:  Leandro de Araujo-Martins; Raphael Monteiro de Oliveira; Gabriela Velozo Gomes dos Santos; Renata Cláudia Celestino dos Santos; Aline Araujo dos Santos; Elizabeth Giestal de Araujo
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

9.  Anti-Pituitary and Anti-Hypothalamus Autoantibody Associations with Inflammation and Persistent Hypogonadotropic Hypogonadism in Men with Traumatic Brain Injury.

Authors:  Sushupta M Vijapur; Zhihui Yang; David J Barton; Leah Vaughan; Nabil Awan; Raj G Kumar; Byung-Mo Oh; Sarah L Berga; Kevin K Wang; Amy K Wagner
Journal:  J Neurotrauma       Date:  2020-04-13       Impact factor: 5.269

Review 10.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.